Dopamine signaling: target in glioblastoma

Print
Published on Monday, 18 April 2016

Dopamine signaling: target in glioblastoma

 



Download the complete article

 

About this publication.

 

See also:

- Recurrent Glioblastoma Multiforme (grade IV – WHO 2007): a case of complete objective response achieved by means of the concomitant administration of Somatostatin and Octreotide – Retinoids – Vitamin E – Vitamin D3 – Vitamin C – Melatonin – D2 R agonists (Di Bella Method – DBM) associated with Temozolomide.